Peptides for hyperpigmentation, such as oligopeptide-68 and decapeptide-12, have been tested only in small studies of 5 to 40 people, usually combined with sunscreen, acids or other lightening agents, so their own effect is unclear.[4][5][6] For melasma and dark spots, an international expert consensus calls daily broad-spectrum sunscreen essential and supervised hydroquinone triple-combination cream the gold standard, with azelaic acid, kojic acid and oral tranexamic acid as alternatives.[1]
This guide covers what to try first, what the peptide studies actually show and the risks of injectable “lightening” products. For background on peptides, see our peptide basics hub.
Evidence-graded table
| Peptide or treatment | Evidence level | What was shown | FDA status | Our profile |
|---|---|---|---|---|
| Broad-spectrum sunscreen | Standard care (expert consensus) | Foundation of every melasma plan[1] | OTC drug | None |
| Hydroquinone triple-combination cream | FDA-approved for this use | Gold standard in expert consensus[1] | Approved (Rx) for short-term treatment of moderate to severe facial melasma[2] | None |
| Azelaic acid, kojic acid, oral tranexamic acid | Human RCTs (varying quality) | Recommended alternatives[1] | Not approved specifically for melasma | None |
| Oligopeptide-68 (with diacetyl boldine) | Small human studies | Melasma improved in 38 women over 12 weeks; no placebo group[4] | Cosmetic ingredient | None |
| Decapeptide-12 | Small human studies | Improvement in a 5-person split-face pilot; 60% lower severity score in a 33-person open-label regimen[5][6] | Cosmetic ingredient | None |
| Glutathione (oral or topical) | Small human studies | Modest melanin reduction; IV use not supported[8] | Not approved for skin lightening | Glutathione |
| New tyrosinase-blocking peptides | Animal or lab only | Designed and tested in cells[7] | Not approved | None |
Results come from different groups of people and are not head-to-head comparisons.
What to try first
Hyperpigmentation covers melasma (hormone- and sun-linked patches), sun spots and dark marks after acne or injury. Melasma is the hardest to treat and tends to come back.
A 2026 Delphi consensus of 38 dermatologists from 11 countries recommends:[1]
- Broad-spectrum sunscreen every day for everyone with melasma
- Hydroquinone-based triple-combination cream, used under medical supervision, as the gold standard
- Azelaic acid, kojic acid or oral tranexamic acid as alternatives
- Chemical peels or microneedling as add-ons, with lasers kept for stubborn cases
In the US, the only FDA-approved hydroquinone product is a prescription cream combining hydroquinone, tretinoin and a corticosteroid. It is approved for short-term treatment of moderate to severe facial melasma, alongside sun avoidance and sunscreen.[2] Since the CARES Act took effect in 2020, over-the-counter hydroquinone skin lighteners are unapproved drugs. FDA has warned that they have caused rashes, facial swelling and ochronosis, a bluish-black skin discoloration that may be permanent.[3]
Oligopeptide-68: what the study really compared
Oligopeptide-68 is marketed as a “TGF-β1 biomimetic” peptide that blocks tyrosinase, the enzyme that makes melanin. Its best-known study enrolled 40 women with melasma; 38 finished.[4]
- Participants used a night serum with diacetyl boldine plus a day cream combining diacetyl boldine, oligopeptide-68 and sunscreen.
- Melasma scores improved at 6 and 12 weeks compared with baseline. Most participants rated themselves moderately improved.
- The comparison with 2% and 4% hydroquinone was done on normal arm skin, not on melasma.
So the study cannot tell you whether oligopeptide-68 itself works, or whether it beats hydroquinone on melasma.
Decapeptide-12: pilots and regimens
Decapeptide-12 is a 10-amino-acid peptide reported to block tyrosinase.
- Pilot RCT: in 5 women with stubborn melasma, twice-daily 0.01% decapeptide-12 on one side of the face improved melasma compared with placebo on the other side over 16 weeks.[5]
- Open-label regimen: 33 Hispanic women used a decapeptide-12 cream, a cleanser, 20% glycolic acid lotion and SPF 30 sunscreen. Melasma severity scores fell 60% by week 16, with no adverse events reported. There was no control group.[6]
Because glycolic acid and sunscreen both lighten pigment, the peptide’s share of the benefit is unknown.
Lab-stage peptides and glutathione
Researchers are designing new peptides to block tyrosinase, adjusting size, charge and ring shape. A 2025 review describes these as promising in the lab, and says studies are still needed to reach clinical use.[7]
Glutathione, a three-amino-acid peptide and antioxidant, is widely sold for skin lightening. A 2025 systematic review found modest melanin reduction with topical 0.5% glutathione and oral doses of 250 to 500 mg a day. It concluded that intravenous glutathione is contraindicated because of lack of efficacy and side effects.[8] In August 2026, FDA reported at least 30 patients with fever, chills and sepsis-like reactions after IV glutathione compounded from dietary-supplement-grade ingredient, consistent with bacterial endotoxin.[9]
Why peptide claims stay vague
Under federal law, a product intended to change the skin’s structure or function is a drug, while one meant to improve appearance is a cosmetic.[10] That is why peptide serums promise a “brighter” or “more even-looking” tone rather than treatment of melasma. Our guides to cosmetic peptide evidence and reading skincare peptide labels explain more.
Procedures are also moving fast. A 2025 network meta-analysis of 14 trials in 738 women found injected platelet-rich plasma among the most effective melasma options, though its authors called for larger trials.[11]
Dark marks after acne and darker skin tones
Dark marks left after acne or injury (post-inflammatory hyperpigmentation) are common in medium and darker skin. Irritation can make them worse, so gentle routines matter. The azelaic acid label notes isolated reports of skin lightening (hypopigmentation) and advises monitoring people with darker complexions.[12] Any lightening product, including peptide serums, should be stopped if it stings, burns or leaves a halo.
Melasma also tends to return. The consensus panel highlighted high recurrence rates and called for better long-term maintenance strategies, so plan on ongoing sun protection even after spots fade.[1]
Questions to discuss with a dermatologist
- Is this melasma, sun damage or a mark from acne, and does that change the plan?
- Is a triple-combination cream or tranexamic acid right for me, and for how long?
- If I want a peptide serum, can it fit into my routine without irritation? Our peptide skincare routine guide can help.
The bottom line
Peptides are a minor, unproven extra for hyperpigmentation. Sun protection and dermatologist-guided treatment do the heavy lifting; peptide serums, at most, play a supporting role.
